Access options
Subscribe to Journal
Get full journal access for 1 year
$59.00
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1
O'Connell MB et al. (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 118: 778–781
- 2
Mizunashi K et al. (1993) Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int 53: 21–25
- 3
Recker RR (1985) Calcium absorption and achlorhydria. N Engl J Med 313: 70–73
- 4
Bo-Linn GW et al. (1984) An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. J Clin Invest 73: 640–647
- 5
Vestergaard P et al. (2006) Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 79: 76–83
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.
Author information
Affiliations
Corresponding author
Ethics declarations
Competing interests
S Amin has received an honorarium from Merck. BL Clarke declared he has no competing interests.
Rights and permissions
About this article
Cite this article
Clarke, B., Amin, S. Does the use of proton-pump inhibitors increase the risk of fracture?. Nat Rev Endocrinol 3, 564–565 (2007). https://doi.org/10.1038/ncpendmet0556
Received:
Accepted:
Published:
Issue Date: